Guangzhou Improve Med Instrument Cash Flow Reinvestment Rate
Guangzhou Improve Med Instrument cash flow reinvestment rate. Guangzhou Improve Med Instrument (300030) has a Cash Flow Reinvestment Rate of 0.05x as of September 2025, reinvesting CN¥3.43 Million (capex CN¥3.43 Million ) from operating cash flow of CN¥70.22 Million. Explore 300030 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Guangzhou Improve Med Instrument (2006–2025)
Cash flow reinvestment rate of Guangzhou Improve Med Instrument from 2006 to 2025. Historical reinvestment intensity for Guangzhou Improve Med Instrument across 18 annual periods. Explore Guangzhou Improve Med Instrument capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Guangzhou Improve Med Instrument Cash Flow Reinvestment Rate by Year (2006–2025)
Guangzhou Improve Med Instrument cash flow reinvestment rate by year from 2006 to 2025. Year-by-year capital reinvestment analysis for Guangzhou Improve Med Instrument. For the full cash flow conversion analysis, see Guangzhou Improve Med Instrument cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.47x | CN¥51.65 Million | CN¥109.90 Million | CN¥24.12 Million | ▼ -34.3% |
| 2024 | 0.72x | CN¥58.55 Million | CN¥81.84 Million | CN¥51.28 Million | ▼ -12.4% |
| 2023 | 0.82x | CN¥65.29 Million | CN¥79.90 Million | CN¥43.70 Million | ▼ -51.3% |
| 2022 | 1.68x | CN¥71.29 Million | CN¥42.48 Million | CN¥58.04 Million | ▲ +275.1% |
| 2021 | 0.45x | CN¥76.84 Million | CN¥171.74 Million | CN¥71.05 Million | ▼ -0.6% |
| 2020 | 0.45x | CN¥63.57 Million | CN¥141.27 Million | CN¥56.82 Million | ▼ -78.8% |
| 2019 | 2.12x | CN¥104.42 Million | CN¥49.16 Million | CN¥54.44 Million | ▲ +116.8% |
| 2018 | 0.98x | CN¥54.89 Million | CN¥56.04 Million | CN¥50.39 Million | ▲ +31.0% |
| 2017 | 0.75x | CN¥106.36 Million | CN¥142.19 Million | CN¥96.01 Million | ▼ -60.4% |
| 2016 | 1.89x | CN¥43.85 Million | CN¥23.19 Million | CN¥26.39 Million | ▲ +34.9% |
| 2013 | 1.40x | CN¥62.21 Million | CN¥44.38 Million | CN¥62.21 Million | ▼ -5.4% |
| 2012 | 1.48x | CN¥53.46 Million | CN¥36.06 Million | CN¥53.46 Million | ▼ -34.6% |
| 2011 | 2.27x | CN¥88.04 Million | CN¥38.86 Million | CN¥88.04 Million | ▼ -7.8% |
| 2010 | 2.46x | CN¥70.86 Million | CN¥28.86 Million | CN¥70.86 Million | ▲ +25.6% |
| 2009 | 1.95x | CN¥64.57 Million | CN¥33.03 Million | CN¥64.57 Million | ▲ +42.8% |
| 2008 | 1.37x | CN¥33.91 Million | CN¥24.76 Million | CN¥33.91 Million | ▼ -63.6% |
| 2007 | 3.76x | CN¥9.97 Million | CN¥2.65 Million | CN¥9.97 Million | ▲ +876.4% |
| 2006 | 0.39x | CN¥2.53 Million | CN¥6.57 Million | CN¥2.53 Million | — |